Fuller & Thaler Asset Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,875
Closed -$380K 533
2026
Q1
$380K Buy
+6,875
New +$327K ﹤0.01% 458
2019
Q3
Sell
-186,582
Closed -$5.93M 488
2019
Q2
$5.93M Sell
186,582
-154,622
-45% -$4.85M 0.07% 198
2019
Q1
$11.3M Sell
341,204
-39,631
-10% -$1.23M 0.14% 141
2018
Q4
$12.2M Sell
380,835
-9,654
-2% -$364K 0.18% 120
2018
Q3
$16.8M Buy
390,489
+43,825
+13% +$2.07M 0.17% 124
2018
Q2
$16M Buy
346,664
+32,214
+10% +$1.43M 0.17% 114
2018
Q1
$12.5M Buy
314,450
+70,900
+29% +$2.63M 0.15% 117
2017
Q4
$8.16M Buy
243,550
+66,300
+37% +$2.35M 0.1% 146
2017
Q3
$6.57M Buy
177,250
+50,100
+39% +$1.88M 0.08% 143
2017
Q2
$4.71M Buy
127,150
+79,600
+167% +$2.6M 0.06% 158
2017
Q1
$1.34M Buy
47,550
+29,700
+166% +$838K 0.02% 250
2016
Q4
$523K Buy
17,850
+16,100
+920% +$439K 0.01% 292
2016
Q3
$48K Hold
1,750
﹤0.01% 599
2016
Q2
$33K Buy
+1,750
New +$36.5K ﹤0.01% 645

Other funds holding PAHC

Fuller & Thaler Asset Management's PAHC Position: Q2 2026 in Review

Fuller & Thaler Asset Management sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 6,875 shares — an estimated $380K sold.

Fuller & Thaler Asset Management first reported a position in PAHC in Q2 2016 and held it in 14 quarters. The position peaked at $16.8M in Q3 2018. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Fuller & Thaler Asset Management reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 6,875 Phibro Animal Health shares in Q2 2026, an estimated $380K.
  • Fuller & Thaler Asset Management first reported a position in Phibro Animal Health in Q2 2016 and held it in 14 quarters.
  • Fuller & Thaler Asset Management's Phibro Animal Health position peaked at $16.8M in Q3 2018.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Fuller & Thaler Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.